Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Immunotherapy|January 27, 2018
Immune modulation by apoptotic dental pulp stem cells in vivoAdam G Laing, Yanira Riffo-Vasquez, Ehsan Sharif-Paghaleh, et al.Plos One|March 15, 2019
Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stressAdam G Laing, Giorgia Fanelli, Andrei Ramirez-Valdez, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 23, 2021
COVID-19: Using high-throughput flow cytometry to dissect clinical heterogeneityIrene Del Molino Del Barrio, Thomas S Hayday, Adam G Laing, et al.Nature Communications|July 30, 2020
Butyrophilin-like proteins display combinatorial diversity in selecting and maintaining signature intraepithelial γδ T cell compartmentsAnett Jandke, Daisy Melandri, Leticia Monin, et al.Science Advances|December 6, 2023
Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentialsPierre Vantourout, Josephine Eum, María Conde Poole, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2023
Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-like AutoimmunityRose Hodgson, Tanya L Crockford, Aneesha Bhandari, et al.Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.Proceedings of the National Academy of Sciences of the United States of America|August 9, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19Magdalene Joseph, Yin Wu, Richard Dannebaum, et al.The Lancet. Oncology|April 30, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyLeticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, et al.Pageof 2